HOME >> MEDICINE >> NEWS
Control of TB epidemic requires more effective drugs, better tests, and focus on latent infection

ATLANTA--With approximately 9 million individuals expected to develop tuberculosis (TB) this year and more than 2 million expected to die from the disease, according to the World Health Organization, tuberculosis has become a global public health epidemic. In the U.S., although TB cases have declined since 1992, it remains a serious health problem in urban areas and among certain populations including some U.S.-born persons. The global TB epidemic increasingly impacts the U.S., where the majority of TB cases now occurring are among people born outside the country.

In an article in the Journal of the American Medical Association published on-line on Tuesday, June 7, clinician/researchers describe the most current effective treatments for both active TB and latent TB infection and the efforts underway to develop new drugs and more effective diagnostic tools. A stepped-up effort targeting programs to detect and treat the large number of people with latent TB infection who are at increased risk for progression to active TB is a strategy for enhancing TB control efforts in the U.S., the authors say.

Effective treatment of active TB requires a minimum of six to nine months of multi-drug therapy. To ensure successful completion of the therapy, these drugs should be administered by using "directly observed therapy," which requires that a health care worker give a patient the drugs then watch the patient swallow them. Directly observed therapy has been demonstrated to enhance completion and cure rates and reduce the risk of emergence of drug-resistant TB.

"Enhancing control of TB in the U.S. requires close collaboration between public health programs and private clinicians," says Henry Blumberg, MD, professor of medicine (infectious diseases) at Emory University School of Medicine, director of infection control at Atlanta's Grady Memorial Hospital and lead author of the JAMA paper. "Our goals with treatment are to cure patients, minimize the
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
7-Jun-2005


Page: 1 2 3

Related medicine news :

1. Controlling prescription drug expenditures: a case report of success
2. SAGE to publish British Journal of Infection Control
3. Controlling antibiotics and antibiotic resistance in hospitals
4. Controlling behavior of children with tourette and tic disorders
5. $900,000 for first Canadian Chair in Hypertension Prevention and Control
6. IAMP expresses support for Disease Control Priorities Project
7. Controlling blood sugar in hospitalized patients saves lives
8. Controlling your (nerve) impulses
9. Controlling neglected tropical diseases will boost fight against HIV, TB, and malaria
10. Controlling neglected tropical diseases could help make poverty history
11. Cigarette use may explain asthma epidemic in children, says Mailman School of Public Health study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, a ... Miami, and Raleigh regions, is organizing an extended charity drive to benefit the ... chromosome abnormality. , After struggling since birth with several health challenges, T.J. was ...
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their approach ... patient is doing more than filling out a survey; in many cases health professionals ... emphasis in health care and research on the importance of active engagement with patients ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
Cached News: